文献速递眼底病与葡萄膜炎

血清脂肪酸结合蛋白4水平预测2型糖尿病患者糖尿病视网膜病变的发生

Circulating Serum Fatty Acid-Binding Protein 4 Levels Predict the Development of Diabetic Retinopathy in Type 2 Diabetic Patients.
PubMed 文献 · Am J Ophthalmol · 2018-01-02

该队列研究连续纳入738例无糖尿病视网膜病变(DR)的2型糖尿病患者并前瞻性随访5年,每年由眼科医生评估视网膜病变。随访期间152例(20.60% [95% CI: 17.68%-23.51%])发生DR,60例(8.13% [95% CI: 6.16%-10.10%])发生视力威胁性DR(VTDR)。校正其他危险因素后,FABP4第三和第四四分位组较第一四分位组的DR调整风险分别增加124%(OR=2.24 [95% CI 1.65-3.68],P=.006)和227%(OR=3.27 [2.04-5.56],P<.001),VTDR调整风险分别增加140%(OR=2.40 [95% CI 1.32-3.82],P=.001)和278%(OR=3.78 [2.17-6.59],P<.001)。

要点

  • 血清FABP4水平与国际临床糖尿病视网膜病变严重程度量表呈正相关(r=0.348;P<.001)。
  • FABP4最高四分位组DR调整风险较第一四分位组增加227%(OR=3.27 [95% CI 2.04-5.56],P<.001)。
  • FABP4最高四分位组VTDR调整风险较第一四分位组增加278%(OR=3.78 [95% CI 2.17-6.59],P<.001)。

核心结论

  • FABP4在中国2型糖尿病患者中显示出作为DR预测新型生物标志物的潜力。
  • 对于FABP4最高四分位范围的2型糖尿病患者,应强调严格血糖控制和更频繁的视网膜检查。

研究设计与样本

  • 队列研究,连续纳入738例无DR的2型糖尿病患者并前瞻性随访。
  • 随访5年内每年由眼科医生进行视网膜病变评估,采用logistic回归模型进行多因素分析。

主要发现

  • 随访期间152例(20.60% [95% CI: 17.68%-23.51%])发生DR,60例(8.13% [95% CI: 6.16%-10.10%])发生VTDR。
  • 血清FABP4水平与国际临床糖尿病视网膜病变严重程度量表呈统计学显著正相关(r=0.348;P<.001)。
  • 校正其他既定危险因素后,FABP4第三四分位组较第一四分位组DR调整风险增加124%(OR=2.24 [95% CI 1.65-3.68],P=.006),第四四分位组增加227%(OR=3.27 [2.04-5.56],P<.001)。
  • 校正后VTDR调整风险第三四分位组较第一四分位组增加140%(OR=2.40 [95% CI 1.32-3.82],P=.001),第四四分位组增加278%(OR=3.78 [2.17-6.59],P<.001)。

关键数值与推荐

  • FABP4第三四分位组DR的OR=2.24(95% CI 1.65-3.68,P=.006),第四四分位组OR=3.27(95% CI 2.04-5.56,P<.001),均以第一四分位组为参照。
  • FABP4第三四分位组VTDR的OR=2.40(95% CI 1.32-3.82,P=.001),第四四分位组OR=3.78(95% CI 2.17-6.59,P<.001),均以第一四分位组为参照。

临床怎么用

  • 作者认为FABP4可能作为中国2型糖尿病患者DR预测的新型生物标志物。
  • 作者建议对FABP4处于最高四分位范围的2型糖尿病患者强调严格血糖控制和更频繁的视网膜检查。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Fatty acid-binding protein 4 (FABP4) has been implicated in the pathology of diabetes and macrovascular diseases. Serum FABP4 levels were determined in type 2 diabetic patients without diabetic retinopathy (DR) at admission in order to investigate a possible contribution of FABP4 to the increased risk of 5-year incidence of DR. DESIGN: Cohort study. METHODS: A total of 738 patients with type 2 diabetes without DR were consecutively enrolled and followed up prospectively. Retinopathy evaluation was annually performed by ophthalmologists in the following 5 years. Multivariate analyses were performed using logistic regression models. RESULTS: During the follow-up period, 152 (20.60% [95% CI: 17.68%-23.51%]) patients developed DR and 60 (8.13% [95% CI: 6.16%-10.10%]) patients developed vision-threatening DR (VTDR). Nonparametric Spearman rank correlation revealed a statistically significant positive correlation between serum FABP 4 level and international Clinical Diabetic Retinopathy Severity Scales (r = 0.348; P < .001). After adjustment for other established risk factors, in multivariate models comparing the third and fourth quartiles against the first quartile of the FABP4, levels of FABP4 were associated with DR and the adjusted risk of DR increased by 124% (OR = 2.24 [95% CI 1.65-3.68], P = .006) and 227% (3.27 [2.04-5.56], P < .001), respectively. Similarly, the adjusted risk of VTDR increased by 140% (OR = 2.40 [95% CI 1.32-3.82], P = .001) and 278% (3.78 [2.17-6.59], P < .001), respectively. CONCLUSION: FABP4 shows potential as a novel biomarker for DR prediction in Chinese patients with T2DM, and strict glycemic control and more frequent retinal examination should be highlighted for T2DM patients with the highest quartile range of FABP4.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Zhang XZ, Tu WJ, Wang H, et al. Circulating Serum Fatty Acid-Binding Protein 4 Levels Predict the Development of Diabetic Retinopathy in Type 2 Diabetic Patients. Am J Ophthalmol. 2018. PMID: 29305311. doi:10.1016/j.ajo.2017.12.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。